Masitinib mesylate | KIT/PDGFR inhibitor | Axon 1419
MDL 100151 | 5-HT2A antagonist | Axon 1103 |
| MDL 100009 | (-)-MDL 100907 | 5-HT2A antagonist | Axon 1105 |
| MDL 100907 (Volinanserin) | (+)-MDL100907 | 5-HT2A antagonist | Axon 1104 Exclusive |
| (-)-MDL 105725 | (-)-MDL105725 | 5-HT2A antagonist | Axon 1108 |
| MDL 105725 | (+)-MDL105725 | 5-HT2A antagonist | Axon 1107 |
(+/-)-MDL 105725 | rac-MDL105725 | 5-HT2A antagonist | Axon 1106
MDL 201012 | M3 antagonist | Axon 1679 Exclusive |
MDV 3100 | Androgen antagonist | Axon 1613
Meclinertant | NK 1 antagonist | Axon 1164 Exclusive |
| 5-Methoxy-2-aminotetralin (SKF 87967) | Axon 1048 |
4-Methylhistamine | H4 agonist | Axon 1261
MG 149 | Tip60 HAT inhibitor | Axon 1785 Exclusive |
| Mifeprestone - RU 486 | PR antagonist | Axon 1502 |
| MK 212 | 5-HT2C agonist | Axon 1214 |
| MK 0354 | Naicin receptor partial agonist | Axon 1576 Exclusive |
| MK 0364 | CB1 inverse agonist | Axon 1550 |
| MK 0457 | Aurora inhibitor | Axon 1540 |
| MK 0524 | DP1 antagonist | Axon 1480 |
| MK 677 | Growth hormone (GH) secretagogue | Axon 1376 |
| MK 767 | PPAR alpha and gamma agonist | Axon 1567 |
| MK 1775 | Wee1 inhibitor | Axon 1494 |
| MK 2206 | Allosteric Akt inhibitor | Axon 1684 |
|
MIBG standard | Axon 1750 |
| Mirtazapine | antidepressant | Axon 1138 |
| MLN 518 | FLT3 inhibitor | Axon 1415 |
| MNITMT | Immunosuppressant | Axon 1267 | NSC 631156 |
| Modafinil | alpha-1 agonist | CRL 40476 | Axon 1296 |
| Molindone | D2 antagonist - MAO inhibitor | Axon 1101 |
| Motesanib | VEGFR/PDGFR/KIT/Ret inhibitor | Axon 1768 New |
| MPEP | mGluR5 antagonist | Axon 1222 |
| MPPF | 5-HT1A antagonist | Axon 1090 |
| MPPI | 5-HT1A antagonist | Axon 1091 |
| MPTP | DA neurotoxin | Axon 1075 |
| MRS 2211 | P2Y13 antagonist | Axon 1263 |
| Myoseverin | Tubulin inhibitor | Axon 1310 |
|
(R)-(+)-5-Methoxy-2-aminotetralin | Axon 1049
(S)-(-)-5-Methoxy-2-aminotetralin | Axon 1050
7-Methoxy-2-aminotetralin | 3880-78-2 | Axon 1054
(R)-(+)-7-Methoxy-2-aminotetralin | 170638-05-8 | Axon 1056
(S)-(-)-7-Methoxy-2-aminotetralin | 158223-16-6| Axon 1055
8-Methoxy-2-aminotetralin | 3880-77-1 | Axon 1057
(R)-8-Methoxy-2-aminotetralin | 127165-18-8 | Axon 1058
(S)-8-Methoxy-2-aminotetralin | 127253-44-5 | Axon 1059
5-Methoxy-N-propyl-2-aminotetralin | DA agonist | Axon 1025
(R)-5-Methoxy-N-propyl-2-aminotetralin | DA agonist | Axon 1026
(S)-5-Methoxy-N-propyl-2-aminotetralin | DA agonist | Axon 1027
6-Methoxy-N-propyl-2-aminotetralin | 69788-83-6 | Axon 1028
7-Methoxy-N-propyl-2-aminotetralin | 93601-93-5 | Axon 1029
(R)-7-Methoxy-N-propyl-2-aminotetralin | 93503-08-3 | Axon 1030
(S)-7-Methoxy-N-propyl-2-aminotetralin | 93503-09-4 | Axon 1031
8-Methoxy-N-propyl-2-aminotetralin | 87394-71-6 | Axon 1032
(R)-8-Methoxy-N-propyl-2-aminotetralin | 78095-32-6 | Axon 1033
(S)-8-Methoxy-N-propyl-2-aminotetralin | 78095-35-9 | Axon 1034
Methyl 3-cyclopentyl-2-(4-methylsulfonylphenyl)propionate | 300355-19-5 | Axon 1135
(-)-N-Methyl-N-(prop-2-ynyl)-2-aminotetralin | DA agonist | Axon 1063
(+)-N-Methyl-N-(prop-2-ynyl)-2-aminotetralin | DA agonist | Axon 1062
N-Methyl-N-n-propyl-2-aminotetralin | DA agonist | Axon 1023 |
| 6-(Methyl-prop-2-ynyl-amino)-5,6,7,8-tetrahydro-naphthalen-1-ol | DA agonist | Axon 1065 |
|
2-(Methylthio)-adenosine | 2-MeS-adenosine | 4105-39-9 | Axon 1192 |
|
|
|
|
|
|
|
|
|
|
